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determinants of disease in these two
populations.
Recruitment of Type I psoriasis
patients for the case cohort was co-
ordinated through the Dermatology
Centre, Hope Hospital, The University
of Manchester, Manchester, UK. All
patients gave written informed consent
and the study was approved by the
Salford and Trafford Local Research
Ethics Committee and conducted ac-
cording to Declaration of Helsinki
Principles.
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TO THE EDITOR
Recent findings suggest that non-mela-
noma skin cancer incidence in young
adults is rising, particularly among US
young women (Christenson et al.,
2005). This raises the important ques-
tion of whether incidence of cutaneous
melanoma, the most lethal form of skin
cancer, is similarly increasing in young
adults. Although melanoma incidence
among US older adults has been
Table 1. Genotype frequencies in IL15 SNPs between UK cohorts of early-onset psoriasis patients and controls
Patients Controls
Genotype Genotype
SNP Samples 1_1 n (%) 1_2 n (%) 2_2 n (%) MAF Samples 1_1 n (%) 1_2 n (%) 2_2 n (%) H-W MAF
Exact
P-value
Trend
test
rs35221404 647 647 (100) 0 (0) 0 (0) 0.000 556 556 (100) 0 (0) 0 (0) NA 0.000 NA NA
rs2322303 639 251 (39.28) 299 (46.79) 89 (13.93) 0.373 475 176 (37.05) 226 (47.58) 73 (15.37) 1.000 0.392 0.6710 0.3785
rs1057972 636 187 (29.4) 303 (47.64) 146 (22.96) 0.468 470 144 (30.64) 245 (52.13) 81 (17.23) 0.222 0.433 0.0608 0.1044
g.96516 656 654 (99.70) 2 (0.30) 0 (0) 0.002 558 558 (100) 0 (0) 0 (0) NA 0.000 0.5028 0.1919
rs10519613 652 525 (80.52) 123 (18.87) 4 (0.61) 0.100 557 454 (81.51) 96 (17.24) 7 (1.26) 0.471 0.099 0.3902 0.8878
rs10519612 646 518 (80.19) 124 (19.20) 4 (0.62) 0.102 471 385 (81.74) 81 (17.20) 5 (1.06) 0.789 0.097 0.5163 0.6616
rs2254514 651 348 (53.46) 253 (38.86) 50 (7.68) 0.271 552 319 (57.79) 196 (35.51) 37 (6.70) 0.358 0.245 0.3214 0.1440
rs1040257 639 341 (53.36) 246 (38.50) 52 (8.14) 0.274 554 282 (50.90) 227 (40.97) 45 (8.12) 1.000 0.286 0.6678 0.5100
rs12510514 649 495 (76.27) 142 (21.88) 12 (1.85) 0.128 554 405 (73.10) 136 (24.55) 13 (2.35) 0.733 0.146 0.4315 0.1961
rs932209 657 186 (28.31) 309 (47.03) 162 (24.66) 0.482 558 160 (28.67) 294 (52.69) 104 (18.64) 0.146 0.450 0.0307 0.1168
rs17461269 649 285 (43.91) 292 (44.99) 72 (11.09) 0.336 553 254 (45.93) 248 (44.85) 51 (9.22) 0.432 0.316 0.5229 0.3062
rs1519551 648 216 (33.33) 299 (46.14) 133 (20.52) 0.436 553 153 (27.67) 275 (49.73) 125 (22.60) 0.932 0.475 0.1044 0.0620
rs990851 644 349 (54.19) 237 (36.80) 58 (9.01) 0.274 487 254 (52.16) 199 (40.86) 34 (6.98) 0.649 0.274 0.2489 0.9976
rs12508866 653 399 (61.10) 217 (33.23) 37 (5.67) 0.223 556 316 (56.83) 209 (37.59) 31 (5.58) 0.730 0.244 0.2781 0.2286
rs3806798 637 515 (80.85) 114 (17.90) 8 (1.26) 0.102 479 392 (81.84) 82 (17.12) 5 (1.04) 0.790 0.096 0.8812 0.6422
1, common variant; 2, rare variant; H-W, Hardy–Weinberg equilibrium; MAF, minor allele frequency; NA, not applicable.
Abbreviations: SEER, the Surveillance, Epidemiology, and End Results Program
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increasing for several decades, there
have been indications that incidence
may be stabilizing for birth cohorts born
after 1945 (Dennis et al., 1993; Hall
et al., 1999). However, in an analysis of
melanoma trends between 1973 and
1997 in the Surveillance, Epidemio-
logy, and End Results (SEER) Program,
Jemal et al. (2001) noted evidence
of an increase among women born
after 1960. Since that analysis, an
additional 7 years of SEER data have
been collected. To better understand
recent trends in melanoma incidence
among young adults, we report findings
from a re-analysis of SEER data,
extended through 2004.
Our analysis was restricted to Cau-
casians from the nine registries that
have contributed data to the SEER
Program since 1973 (Atlanta, Connecti-
cut, Detroit, Hawaii, Iowa, New Mex-
ico, San Francisco-Oakland, Seattle,
Utah). We calculated annual age-ad-
justed incidence (SEER Program, 2007a)
and mortality rates (SEER Program,
2007b) of invasive cutaneous melano-
ma among men and women aged
15–39 years, standardized to the 2000
US population, using the software
SEER*Stat version 6.3.6 (National Can-
cer Institute; http://www.seer.cancer.
gov/seerstat/). We assessed trends in
greater detail using joinpoint regression
models, which identify changes in
trends over successive segments of time
and describe the estimated annual
percent change (EAPC) in incidence
within each segment (Kim et al.,
2000), using the software Joinpoint
version 3.0 (National Cancer Institute;
http://www.srab.cancer.gov/joinpoint/).
Joinpoint analyses stratified by melano-
ma stage (localized vs regional/distant)
and thickness (p1 vs 41mm) were
also performed. To describe age-
specific trends by year of birth, we
calculated incidence by 5-year age
groups and time periods, and plotted
age-specific incidence by calendar year
of birth (calculated from the age
group midpoint). Additionally, age–
period–cohort modeling was used to
simultaneously adjust age-specific in-
cidence trends for both calendar period
and birth cohort effects (Tarone
and Chu, 2000). All P-values were
two-sided.
Overall, the age-adjusted annual
incidence of melanoma among young
men increased from 4.7 cases per
100,000 persons (95% confidence lim-
its: 3.8, 5.7) in 1973 to 7.7 per 100,000
in 2004 (6.8, 8.7). Among women, age-
adjusted annual incidence per 100,000
increased from 5.5 (4.5, 6.6) in 1973 to
13.9 (12.7, 15.2) in 2004. Melanoma
incidence increased among young men
(EAPC¼ 6.6; 95% confidence limits
(CL): 2.9, 10.4) and women (9.2; 6.8,
11.7) during the 1970s (Figure 1, Ta-
ble 1). Around the start of 1980, this
pattern changed. For men, incidence
leveled off between 1980 and 2004
(0.4; 0.2, 0.9). For women, the rate of
increase in incidence declined from
1978 to 1987 (2.6; 1.5, 3.8) and
stabilized from 1987 to 1992 (0.6;
3.7, 2.6). After 1992, however, in-
cidence began increasing again (2.7;
2.1, 3.4). Incidence among women
from the 1990s onward increased both
for thinner and thicker melanomas
(p1mm: 3.1; 2.5, 3.6 and 41mm:
2.8; 1.6, 4.0), and was greater for
regional and distant tumors (9.2; 3.8,
14.9) compared with localized lesions
(1.9; 1.6, 2.3). Melanoma mortality
rates for men and women declined
from 1981 onward (men: 3.6; 4.5,
2.7 and women: 2.3; 3.1, 1.5).
Age-specific incidence patterns by
year of birth are presented in Figure 2.
Male age-specific incidence increased
steadily with each successive birth
cohort until 1950, at which time
incidence appeared to level off or
decrease slightly. Female age-specific
incidence by birth cohort increased
steadily until around 1950; thereafter,
incidence appeared to climb at a
slower pace until 1965, at which point
incidence appeared to begin accelerat-
ing. After adjustment for age and period
effects, age–period–cohort modeling
confirmed a change in the effect of
birth cohort for women born between
1960 and 1965 (Figure S1; slope
change parameter¼0.2146; 95% CL:
0.0576, 0.3716; P¼0.007).
It is important to consider whether
these trends may reflect changes in
data quality, diagnosis, or surveillance.
There is evidence of increased under-
reporting of melanoma over time with-
in the SEER program, with estimates
as high as 17% of all cases (including
in situ lesions) in two registries,
although such a trend in underreporting
cannot explain the observed increase
in incidence among women (Seiffert,
1992; Merlino et al., 1997). It is
unlikely that a change in melanoma
diagnostic criteria would account for
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Figure 1. Trends in melanoma incidence and mortality among young adults. Age-adjusted (to 2000 US
population) annual cutaneous melanoma incidence and mortality rates among Caucasian males and
females aged 15–39 years in the Surveillance, Epidemiology, and End Results Program areas from 1973
through 2004. The segments of uniform trend from the best-fitting Joinpoint models are also shown.
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our finding, because the effect of such a
change would not be expected to be
sex-specific. Changes in screening pat-
terns may have led to earlier detection
within this time period, with a higher
rate of increase seen among superficial
localized tumors compared with thicker
lesions and regional or metastatic dis-
ease overall (Jemal et al., 2001; Welch
et al., 2005). Indeed, the observed
decrease in melanoma mortality rates
after 1981 and previously reported
evidence of general improvement in
survival by stage over this time period
are consistent with a shift toward earlier
detection of disease through increased
surveillance (Jemal et al., 2001). How-
ever, in our analysis, the increasing
trend among young women from the
early 1990s onward was also observed
for thicker and regional/distant tumors,
which are less susceptible to misclassi-
fication. Moreover, our age–period–co-
hort analysis suggested that, after
adjusting for age and period effects
(the latter of which is reflective of
changes in disease surveillance), the
observed increase in incidence among
women born after 1965 is consistent
with a birth cohort effect (indicative of
changes in disease risk factor preva-
lence across birth cohorts; Tarone and
Chu, 2000). Thus, our findings are
compatible with a real increase in
incidence among young women,
although we cannot rule out the effects
of changes in surveillance.
The recent increase in incidence
among young women parallels reported
trends in exposure to UVR, the primary
environmental cause of melanoma
(Armstrong and Kricker, 2001). The
prevalence of sunburn is increasing
among US adult men and women
overall, although trends by age group
have not been reported (Robinson et al.,
1997; Saraiya et al., 2007). Among
adolescents aged 16–18 years, both
Table 1. EAPC in incidence of melanoma and melanoma mortality among Caucasian males and females aged 15–39
years in the SEER Program from 1973 through 2004
Trend 1 Trend 2 Trend 3 Trend 4
Years1 EAPC (95% CL) Years EAPC (95% CL) Years EAPC (95% CL) Years EAPC (95% CL)
Incidence
Overall
Males 1973–1980 6.6 (2.9, 10.4) 1980–2004 0.4 (0.2, 0.9)
Females 1973–1978 9.2 (6.8, 11.7) 1978–1987 2.6 (1.5, 3.8) 1987–1992 0.6 (3.7, 2.6) 1992–2004 2.7 (2.1, 3.4)
By stage
Localized
Males 1973–1980 9.6 (4.9, 14.5) 1980–2004 0.5 (0.2, 1.2)
Females 1973–1978 15.8 (10.9, 21.0) 1978–2004 1.9 (1.6, 2.3)
Regional/distant
Males 1973–2004 1.4 (0.6, 2.2)
Females 1973–1994 0.9 (2.5, 0.8) 1994–2004 9.2 (3.8, 14.9)
By thickness (1988+ only)
p1mm
Males 1988–2004 2.3 (1.2, 3.4)
Females 1988–2004 3.1 (2.5, 3.6)
41mm
Males 1988–2004 0.3 (1.5, 1.0)
Females 1988–2004 2.8 (1.6, 4.0)
Mortality
Males 1973–1981 5.0 (0.3, 10.1) 1981–2004 3.6 (4.5, 2.7)
Females 1973–2004 2.3 (3.1, 1.5)
CL, confidence limits; EAPC, estimated annual percent change in melanoma incidence within jointpoint segment.
Statistically significant results in bold face type.
1Calendar period within joinpoint segment. Joinpoint modeling was carried out separately for males and females; hence, sex-specific joinpoint segments
may differ.
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the prevalence of sunburn and the
average number of days spent at the
beach increased between sun surveys
conducted in 1998 and 2004 (Cokki-
nides et al., 2006). Tanning bed usage,
which has been recently evaluated as a
probable cause of melanoma (Interna-
tional Agency for Research on Cancer,
2007), is increasing among US adults
and is most prevalent among
young women (Robinson et al., 1997;
Lazovich and Forster, 2005).
In conclusion, our analysis of SEER
data suggests that melanoma incidence
is increasing among young women.
Additional studies are needed to clarify
whether the increasing trends for mel-
anoma and non-melanoma skin cancer
(Christenson et al., 2005) are the result
of changes in UVR exposure in this
population.
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SUPPLEMENTARY MATERIAL
Figure S1. Sex-specific maximum likelihood
estimates of 5-year birth cohort effects for an
age-period-cohort model fit to cutaneous melano-
ma incidence data for Caucasians in the SEER
Program from 1973 through 2004.
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Figure 2. Age-specific melanoma incidence among Caucasians stratified by sex and birth cohort year in the SEER program from 1975–1979 through
2000–2004. The points vertically above each cohort year portray the cohort’s age-specific incidence experience. The vertical line at 1965 on the x axis of the
plot for women represents the time point after which melanoma incidence begins increasing in subsequent cohorts.
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